STOML2 as a novel prognostic biomarker modulates cell proliferation, motility and chemo-sensitivity via IL6-Stat3 pathway in head and neck squamous cell carcinoma.
Am J Transl Res
; 11(2): 683-695, 2019.
Article
en En
| MEDLINE
| ID: mdl-30899371
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Idioma:
En
Año:
2019
Tipo del documento:
Article